In the News

New network to support global investigators and research sites participating in decentralized clinical trials for pharmaceutical and biotech customers.

The ongoing expansion of our bioanalytical operations builds on the growth of our drug development expertise over nearly four decades.

State-of-the art bioanalytical lab in Richmond, Virginia, will support increasing demand across biopharma for consistent, high-quality laboratory services to accelerate drug development.

More than 150 leaders at global biotech and pharmaceutical organizations assessed the therapies in their pipelines, barriers to bringing drugs to market, innovations in pursuit and lingering effects of COVID-19.

The authors discuss how a more crowded space is presenting new challenges that must be addressed to improve efficiency.

The authors explore the latest draft guidance and review industry best practices to increase diversity in clinical trials.

Soren Skovlund outlines what it takes to be a patient-first organization and how companies can better ensure they are delivering experiences that meet patients’ expectations.

Respondents to survey say the top challenge drug developers are currently facing is patient recruitment.

Amy Lavelle discusses the challenges of performing bioanalytical studies and how CROs can help mitigate possible regulatory submission problems.